Pulse Biosciences, Inc. | A bioelectric medicine company pursuing commercial introduction of our CellFX™ System utilizing our proprietary, groundbreaking Nano-Pulse Stimulation (NPS™) technology.
Nano-Pulse Stimulation (NPS) technology is our proprietary technology that delivers nano-second pulses of high-amplitude electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue. The proven cell-specific effects of NPS technology are repeatedly being validated in a series of ongoing clinical trials. In addition, early pre-clinical evidence suggests that the NPS mechanism holds a promising future in immuno-oncology by demonstrating an ability to induce immunogenic cell death.
read more >
Review the latest press releases, news and events. view all news >
View all job positions >
Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that will improve and extend the lives of patients. We utilize our patented, groundbreaking Nano-Pulse Stimulation (NPS) technology to treat a variety of applications for which an optimal solution remains unfulfilled. The CellFX System is our first planned commercial product that harnesses the distinctive advantages of our NPS technology as a multi-application platform designed to address a broad range of dermatologic conditions.
read more >